Drug
Estramustine clinical trials
Also written Emcyt.
- studies test it
- 48
- open now
- 0
- in phase 3
- 8
- first study started
- 1995
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
48 studies that test it; most in 2001 (8)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 2 |
| 1997 | 2 |
| 1998 | 7 |
| 1999 | 3 |
| 2000 | 6 |
| 2001 | 8 |
| 2002 | 7 |
| 2003 | 4 |
| 2004 | 3 |
| 2006 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 36
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 47
M.D. Anderson Cancer Center (4) · Eastern Cooperative Oncology Group (3) · Alliance for Clinical Trials in Oncology (3) · University of Michigan Rogel Cancer Center (3) · Memorial Sloan Kettering Cancer Center (3) · Herbert Irving Comprehensive Cancer Center (3) · Radiation Therapy Oncology Group (2) · Dana-Farber Cancer Institute (2)
Often tested with
Tested in the same studies.
Docetaxel (21) · Paclitaxel (16) · Doxorubicin (8) · Ketoconazole (7) · Carboplatin (6) · Vinblastine (3) · Etoposide (3) · Thalidomide (3)
Studies
Open first, then newest update. How each study uses Estramustine is read from its arms, and is right about nine times in ten.
Testing it · 48
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedPhase 2Eastern Cooperative Oncology GroupNCT00005847Written as estramustine phosphate sodium
- Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate CancerCompletedPhase 2Eastern Cooperative Oncology GroupNCT00003614Written as estramustine phosphate sodium
- Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate CancerCompletedPhase 3Eastern Cooperative Oncology GroupNCT00027859Written as estramustine phosphate sodium
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompletedPhase 3UNICANCERNCT00055731Written as Estramustine phosphate sodium
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedPhase 3Radiation Therapy Oncology GroupNCT00030654Written as estramustine phosphate sodium
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerCompletedPhase 3Radiation Therapy Oncology GroupNCT00004054Written as estramustine phosphate sodium
- Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.CompletedPhase 2Institut de Cancérologie de LorraineNCT02866955Written as Estramustine
- Efficacy and Safety of Estracyt® in Metastatic Breast CancerWithdrawnPhase 2Centre Hospitalier Universitaire de BesanconNCT02853071Written as Estramustine
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate CancerTerminatedPhase 2The University of Texas Health Science Center, HoustonNCT02560051Written as Estramustine
- Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate CancerTerminatedPhase 2The University of Texas Health Science Center, HoustonNCT02494713Written as Estramustine
- Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaCompletedPhase 1/2M.D. Anderson Cancer CenterNCT00038246Written as Estramustine
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedPhase 3M.D. Anderson Cancer CenterNCT00002855Written as Estramustine Phosphate Sodium
- Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local TreatmentCompletedPhase 2Dana-Farber Cancer InstituteNCT00165399Written as Estramustine
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00005810Written as estramustine phosphate sodium
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00016913Written as estramustine
- Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00052845Written as estramustine phosphate sodium
- Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCompletedPhase 2University of New MexicoNCT00003584Written as estramustine phosphate sodium
- Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerTerminatedPhase 3M.D. Anderson Cancer CenterNCT00024167Written as Estramustine phosphate sodium
- Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedPhase 2University of Michigan Rogel Cancer CenterNCT00151073Written as Estramustine
- Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate CancerCompletedPhase 1/2University of Michigan Rogel Cancer CenterNCT00151086Written as Estramustine
See all 48 studies that test Estramustine →
Given in every arm · 2 — Estramustine is usual care beside what is tested
- Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate CancerCompletedPhase 2Beth Israel Deaconess Medical CenterNCT01250717Written as Estramustine
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerCompletedPhase 2M.D. Anderson Cancer CenterNCT00003084Written as Estramustine phosphate sodium
Codes
What other systems call Estramustine · ClinicalTrials.gg INT007442
- MeSH (NLM) D004961EstramustineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 35LT29625AESTRAMUSTINEConfirmed FDA, NLM, Wikidata
- RxNorm 4089Confirmed FDA, Wikidata
- Wikidata Q412939estramustineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C479EstramustineOne source FDA
- DrugBank DB01196One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004961 | Estramustine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 35LT29625A | ESTRAMUSTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4089 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412939 | estramustine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C479 | Estramustine | One source FDA |
| DrugBank | DB01196 | — | One source Wikidata |
Also registered as estramustine phosphate (UNII MUZ9585Y7B · RxNorm 105556) and estramustine phosphate sodium (UNII 75F375MT2N · RxNorm 4090).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.